Trials / Withdrawn
WithdrawnNCT02145689
Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a long-term safety and efficacy study of onabotulinumtoxinA in poststroke patients with upper limb spasticity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | onabotulinumtoxinA | Up to 4 treatments of onabotulinumtoxinA injected into muscles of the study limb on fulfillment of the retreatment criteria. |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2014-05-23
- Last updated
- 2014-08-13
Source: ClinicalTrials.gov record NCT02145689. Inclusion in this directory is not an endorsement.